Search Constraints
Filtering by:
Subject
Glioblastoma multiforme -- Tratamiento
Remove constraint Subject: Glioblastoma multiforme -- Tratamiento
Description: | Glioblastoma is the most aggressive brain tumor with a low median survival of 14 months. The only Food and Drug Administration (FDA)-approved treatment for topical delivery of the cancer drug carmustine is Gliadel. However, its use has been associated with several side-effects, mainly induced by a mass effect. Nitrogendoped carbon... |
---|---|
Subject: | Gliomas and Glioblastoma multiforme -- Tratamiento |
Creator: | Salazar Ramiro, Alelí Janet |
Contributor: | Orozco Morales, Mario, Pineda Olvera, Benjamín, González Esquivel, Dinorah Fabiola, Jiménez Anguiano, Anabel, González Camarena, Ramón, and Pérez de la Cruz, Verónica |
Publisher: | Universidad Autónoma Metropolitana |
Posgrado: | Doctorado en Biologia Experimental |
Language: | spa |
Año de publicación: | 2021 |
Rights Statement*: | Acceso Abierto |
License: | Atribucion-NoComercial 4.0 Internacional (CC BY-NC 4.0) |
Tipo de Recurso: | info:eu-repo/semantics/doctoralThesis |
Identifier: | https://doi.org/10.24275/uami.tm70mv401 |